Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Endpoint Determination Study Protocol

ClinicalTrials.gov ID: NCT03459482

Public ClinicalTrials.gov record NCT03459482. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Endpoint Determination Study for An Antibody Guided Dietary Restriction Trial Using Biomerica InFoods® IBS Test in Patients With a Previous Diagnosis of Irritable Bowel Syndrome (IBS)

Study identification

NCT ID
NCT03459482
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Biomerica
Industry
Enrollment
556 participants

Conditions and interventions

Interventions

  • Food Elimination Diet Other

Other

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 20, 2018
Primary completion
Dec 30, 2021
Completion
Dec 30, 2021
Last update posted
Aug 4, 2024

2018 – 2021

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Mayo Clinic Scottsdale Arizona 85259
Mayo Clinic Jacksonville Florida 32224
Family Medicine Specialists Wauconda Illinois 60084
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
University of Michigan Health System Ann Arbor Michigan 48109-5362
Houston Methodist Research Institute Houston Texas 77030
UT Health Houston Texas 77030
Gastroenterology Research of San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03459482, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 4, 2024 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03459482 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →